| Ytd | 93.41% | |
| 1y | 109.34% |
| Open | 78.24 | Prev Close | 78.75 | Low | 78.23 | High | 80.50 | Mkt Cap | 6.22B |
| Vol | 430.28K | Avg Vol | 573.74K | EPS | 1.00 | P/E | 79.78 | Forward P/E | 49.32 |
| Beta | 0.04 | Short Ratio | 7.89 | Inst. Own | 100.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 77.47 | 200-d Avg | 56.92 | 1yr Est | 98.00 |
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA - Get Free Report) has earned a consensus r
KNSA is gaining momentum as Arcalyst sales surge and pipeline advances strengthen prospects for cont
LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA)
Kiniksa Pharmaceuticals International NASDAQ: KNSA said its commercialized recurrent pericarditis tr
LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA)
KNSA lifted 2026 ARCALYST sales guidance as Q2 revenue surged, while advancing KPL-387 into Phase 3
Kiniksa Pharmaceuticals International, plc (KNSA) shares have started gaining and might continue mov
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se
US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Ph
Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2026 Earnings Call Transcript
U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet
Kiniksa Pharmaceuticals International NASDAQ: KNSA reported second-quarter ARCALYST revenue of $243.
Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.3 per share
- ARCALYST¨ (rilonacept) Q2 2026 net product revenue of $243. 6 million, representing ~55% year-over
Despite a volatile market, AOUT, CMPR, NESR, CTO and KNSA are five stocks showing recent price stren
If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pha
Let's take a look at four stocks, FLXS, ARKO, KNSA and BSET, with impressive net profit margins for
Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice for investors looking to m
Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for
Kiniksa Pharmaceuticals International, plc (KNSA) was a big mover last session on higher-than-averag
Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and risin
KNSA's Arcalyst sales continue to grow as raised 2026 revenue guidance and an expanding IL-1 pipelin
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimate
Oversold stocks in health care sector present buying opportunity. RSI compares stock's strength
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you
Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third q
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Companies Reporting Before The Bell • Unilever (NYSE:UL) is expected to report earnings for its fir
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for
On Wednesday, 807 companies reached new 52-week lows.
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo
On Monday, 671 companies achieved new lows for the year.
On Monday morning, 207 companies hit new 52-week lows.
Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows.